Home › Diffuse Large B-Cell Lymphoma › Louisiana
Diffuse Large B-Cell Lymphoma clinical trials in Louisiana
6 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in Louisiana.
Cities in Louisiana
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Mary Bird Perkins Cancer Center, Baton Rouge
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05006716A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Our Lady of the Lake Physician Group-Medical Oncology ( Site 0180), Baton Rouge
- Ochsner LSU Health - Monroe Medical Center, Family Medicine Clinic ( Site 0209), Monroe
- Ochsner Clinic Foundation ( Site 0189), New Orleans
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06890884A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- CHRISTUS St. Frances Cabrini Hospital Center for Cancer Care ( Site 0184), Alexandria
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06717347Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Mary Bird Perkins Cancer Ctr, Baton Rouge
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06806033Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Louisiana State University Health Sciences Center, Shreveport
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Tulane Cancer Center Office of Clinical Research, New Orleans
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 7, 2023 · NCT04920617From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.